NASDAQ: SRZN - Surrozen, Inc.

छह महीने के लिए लाभप्रदता: -6.5%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Surrozen, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में

Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. The company is developing antibody-based therapeutics with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.

अधिक जानकारी
Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcoholic hepatitis and asialoglycoprotein receptor 1; and SZN-1326, a bi-specific antibody, which is in Phase 1b clinical trial for the treatment of moderate to severe inflammatory bowel disease, Frizzled, and LRP receptors. The company also develops SZN-413, a Fzd4 targeted bi-specific antibody, which is in preclinical stage for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. was founded in 2015 and is based in South San Francisco, California.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

Цена ао 13.65
Выручка 0.0125
EBITDA -0.0228
P/S 1.47
P/BV 2.06
EV/EBITDA 1.28
ISIN US86889P1093
Сайт https://www.surrozen.com
Число акций ао 0.00202 млрд
Валюта usd
IPO date 2021-01-11
Sector Health Care
Industry Biotechnology
Валюта отчета usd
प्रति दिन मूल्य परिवर्तन: -4.37% (10.98)
प्रति सप्ताह मूल्य परिवर्तन: +1.64% (10.33)
प्रति माह मूल्य परिवर्तन: +2.54% (10.2399)
3 महीने में कीमत में बदलाव: +6.6% (9.85)
छह महीने में कीमत में बदलाव: -6.5% (11.2299)
प्रति वर्ष मूल्य परिवर्तन: +2 254.24% (0.446)
3 वर्षों में मूल्य परिवर्तन: +6.92% (9.82)
वर्ष की शुरुआत से मूल्य परिवर्तन: +2 347.53% (0.429)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 1.35 9
P/BV 0.4458 10
P/E 0 0
EV/EBITDA 0.3831 10
कुल: 6.13

क्षमता

नाम अर्थ श्रेणी
ROA, % -93.41 0
ROE, % -113.46 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.0822 10
कुल: 9.8

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 0 0
लाभप्रदता Ebitda, % 80.34 9
लाभप्रदता EPS, % 416.44 10
कुल: 7.2
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Column Group LLC 627651 19.62
Euclidean Capital LLC 87696 2.74
Blackrock Inc. 58494 1.83
ArrowMark Colorado Holdings LLC 55123 1.72
Board Of Trustees Of The Leland Stanford Junior University 52131 1.63
Trustees Of Columbia University In The City Of New York 47930 1.5
Morgan Stanley 35211 1.1
Vanguard Group Inc 32511 1.02
Alyeska Investment Group, L.P. 20376 0.64
Geode Capital Management, LLC 11473 0.36

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
iShares Micro-Cap ETF 0.00519 36.318555985322 1.54048



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Craig C. Parker M.B.A. CEO, President & Director 825.32k 1962 (62 वर्ष)
Mr. Charles Williams CFO, COO & Corporate Secretary 611.03k 1980 (44 वर्ष)
Dr. K. Christopher Garcia Ph.D. Co-Founder & Member of Scientific Advisory Board N/A
Dr. Roeland Nusse Ph.D. Co-Founder & Member of Scientific Advisory Board N/A 1950 (74 वर्ष)
Dr. Calvin Kuo M.D., Ph.D. Co-Founder & Member of Scientific Advisor N/A
Dr. Li Yang Ph.D. Executive Vice President of Research 535.46k 1969 (55 साल)
Esther Jhun Controller N/A

पता: United States, South San Francisco. CA, 171 Oyster Point Boulevard - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.surrozen.com